Dan Crandall

Dan Crandall, CPA, CA has extensive work experience in various financial and leadership roles. Dan is currently serving as the Director of Finance at Cardiol Therapeutics Inc., a clinical-stage life sciences company focused on developing therapies for heart disease. Dan has also held positions as the Director and Audit Committee Chair at West Red Lake Gold Mines Inc., where they served from 2020 to 2022 and from 2015 to 2019.

In addition, Dan has held the role of Chief Financial Officer at multiple companies, including Zonetail, Giyani Metals Corp., Abaxx Technologies, Inc., Rockcliff Metals Corporation, COIN Hodl Inc., Chilean Metals Inc., and Royal Standard Minerals Inc. These roles were held between 2014 and 2019, showcasing their expertise in financial management and strategy.

Dan Crandall, CPA, CA completed an Honours Bachelor of Accounting (Co-op) degree at Brock University from 2002 to 2007.